☆ 4.3 Editorial Material

Possible new therapeutic agents for malignant pleural mesothelioma: anti-CD26 monoclonal antibody and naftopidil

EXPERT REVIEW OF ANTICANCER THERAPY (2016)

Get Full Text
Add to Collection

Journal

EXPERT REVIEW OF ANTICANCER THERAPY
Volume 16, Issue 11, Pages 1097-1099

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1080/14737140.2016.1241150

Keywords

Mesothelioma; beta-blockers; naftopidil; CD26; dipeptidyl peptidase IV; anti-CD26 monoclonal antibody; amatuximab; nintedanib

Categories

Oncology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.